Hey there. Former chemotherapy patient for breast cancer here. When I was receiving chemo every week at the oncology clinic, one of the drugs they gave me so my body wouldn't freak out from the anticancer poisons was Dexamethasone. It's a really important drug for many cancer patients.
Some people are going to misinterpret news of a clinical trial making the rounds today today as meaning that they should get a hold of some dexamethasone right away and start taking it as a prophylaxis, or preventative, against COVID-19. Don't do this.
No no no. No.
Please do not do this.
That's not how this works.
Do not take Dexamethasone to prevent COVID-19.
Ask a medical professional for advice, first.
The news involved some hopeful news from a clinical trial.
Don't take drugs based on Facebook headlines or do anything like this without a doctor's guidance.
— World Health Organization (WHO) (@WHO) June 16, 2020
Please, please, don't start taking dexamethasone as an attempt at COVID prophylaxis; the entire medical profession implores you.
— Ed Hutchison (@EdHutchison) June 16, 2020
OH DEAR GOD this hadn't even occurred to me
FOR THE LOVE OF ALL THAT IS HOLY, DON'T TAKE DEXAMETHASONE UNLESS IT IS PRESCRIBED BY A QUALIFIED CLINICIAN!!!!!!!!! https://t.co/1BMDFniTaB
— NYSuri (@nysuri) June 16, 2020
Lots of hype about Dexamethasone, no doubt to be followed by demands for prescriptions. Please don't. There's no evidence (or reason to even suspect) it PREVENTS Covid-19. Current study is about supporting severely respiratory compromised patients who are already infected.
— matt blaze (@mattblaze) June 16, 2020
Yes. I, too, would like to see the #dexamethasone paper. But.
1) It is plausible,
2) It's a respected research team
3) We gave the Remdesivir team ≈ weeks.
4) it is an RCT.
I will stay optimistic and hopeful, and appraise the paper when it comes out. #COVID19
— John Mandrola, MD (@drjohnm) June 16, 2020
— Mukesh Kapila (@mukeshkapila) June 16, 2020
Prof. Landry, the lead investigator of "major breakthrough" trial of Dexamethasone, explains the treatment's use: "The patients on ventilation [and oxygen] received this big reduction in the risk. But in other patients we do not see a reduction." https://t.co/bcGg6sCEvh pic.twitter.com/5jcT596pAS
— CNBC (@CNBC) June 16, 2020
Today we are seeing tons of hype around the corticosteroid dexamethasone, prompted by this press release.
— Carl T. Bergstrom (@CT_Bergstrom) June 16, 2020